AAAAAA

   
Results: 1-9 |
Results: 9
PHASE-I TRIAL OF INTRAPERITONEAL IODODEOXYURIDINE WITH AND WITHOUT INTRAVENOUS HIGH-DOSE FOLINIC ACID IN THE TREATMENT OF ADVANCED MALIGNANCIES PRIMARILY CONFINED TO THE PERITONEAL-CAVITY - FLOW CYTOMETRIC ANDPHARMACOKINETIC ANALYSIS
Authors: MORGAN RJ NEWMAN EM DOROSHOW JH MCGONIGLE K MARGOLIN K RASCHKO J CHOW W SOMLO G LEONG L TETEF M SHIBATA S HAMASAKI V CARROLL M VASILEV S AKMAN S COLUZZI P WAGMAN L LONGMATE J PAZ B YEN Y KLEVECZ R
Citation: Rj. Morgan et al., PHASE-I TRIAL OF INTRAPERITONEAL IODODEOXYURIDINE WITH AND WITHOUT INTRAVENOUS HIGH-DOSE FOLINIC ACID IN THE TREATMENT OF ADVANCED MALIGNANCIES PRIMARILY CONFINED TO THE PERITONEAL-CAVITY - FLOW CYTOMETRIC ANDPHARMACOKINETIC ANALYSIS, Cancer research, 58(13), 1998, pp. 2793-2800
HIGH-DOSE INFUSIONAL DOXORUBICIN AND CYCLOPHOSPHAMIDE - A FEASIBILITYSTUDY OF TANDEM HIGH-DOSE CHEMOTHERAPY CYCLES WITHOUT STEM-CELL SUPPORT
Authors: MORGAN RJ DOROSHOW JH VENKATARAMAN K CHANG K RASCHKO J SOMLO G LEONG L TETEF M SHIBATA S HAMASAKI V MARGOLIN K FORMAN S AKMAN S COLUZZI P AHN C WEISS L GADGIL U HARRISON J
Citation: Rj. Morgan et al., HIGH-DOSE INFUSIONAL DOXORUBICIN AND CYCLOPHOSPHAMIDE - A FEASIBILITYSTUDY OF TANDEM HIGH-DOSE CHEMOTHERAPY CYCLES WITHOUT STEM-CELL SUPPORT, Clinical cancer research, 3(12), 1997, pp. 2337-2345
HIGH-DOSE CHEMOTHERAPY AND STEM-CELL RESCUE IN THE TREATMENT OF HIGH-RISK BREAST-CANCER - PROGNOSTIC INDICATORS OF PROGRESSION-FREE AND OVERALL SURVIVAL
Authors: SOMLO G DOROSHOW JH FORMAN SJ ODOMMARYON T LEE J CHOW W HAMASAKI V LEONG L MORGAN R MARGOLIN K RASCHKO J SHIBATA S TETEF M YEN Y SIMPSON J MOLINA A
Citation: G. Somlo et al., HIGH-DOSE CHEMOTHERAPY AND STEM-CELL RESCUE IN THE TREATMENT OF HIGH-RISK BREAST-CANCER - PROGNOSTIC INDICATORS OF PROGRESSION-FREE AND OVERALL SURVIVAL, Journal of clinical oncology, 15(8), 1997, pp. 2882-2893
PHARMACOKINETICS AND TOXICITY OF 120-HOUR CONTINUOUS-INFUSION HYDROXYUREA IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: NEWMAN EM CARROLL M AKMAN SA CHOW W COLUZZI P HAMASAKI V LEONG LA MARGOLIN KA MORGAN RJ RASCHKO JW SHIBATA S SOMLO G TETEF M YEN Y AHN CW DOROSHOW JH
Citation: Em. Newman et al., PHARMACOKINETICS AND TOXICITY OF 120-HOUR CONTINUOUS-INFUSION HYDROXYUREA IN PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 39(3), 1997, pp. 254-258
RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN COMBINATION WITH G-CSF ISSAFE AND EFFECTIVE AS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZER
Authors: SOMLO G SNIECINSKI I BRENT J TERVEER A CHOW W FORMAN S HAMASAKI V LEONG L MORGAN R MARGOLIN K RADER D RASCHKO J SHIBATA S TETEF M YEN Y MOLINA A ASHBY M JONES D DOROSHOW JH
Citation: G. Somlo et al., RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN COMBINATION WITH G-CSF ISSAFE AND EFFECTIVE AS PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZER, Blood, 90(10), 1997, pp. 2513-2513
EFFECT OF CD34(-CELL REINFUSION AND GRANULOCYTE-COLONY-STIMULATING FACTOR PRIMING ON HEMATOPOIETIC RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER() SELECTION AND VARIOUS SCHEDULES OF STEM)
Authors: SOMLO G SNIECINSKI I ODOMMARYON T NOWICKI B CHOW W HAMASAKI V LEONG L MARGOLIN K MORGAN R RASCHKO J SHIBATA S TETEF M MOLINA A BERENSON RJ FORMAN SJ DOROSHOW JH
Citation: G. Somlo et al., EFFECT OF CD34(-CELL REINFUSION AND GRANULOCYTE-COLONY-STIMULATING FACTOR PRIMING ON HEMATOPOIETIC RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER() SELECTION AND VARIOUS SCHEDULES OF STEM), Blood, 89(5), 1997, pp. 1521-1528
TREATMENT OF GERM-CELL CANCER WITH 2 CYCLES OF HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE WITH AUTOLOGOUS STEM-CELL SUPPORT
Authors: MARGOLIN K DOROSHOW JH AHN C HAMASAKI V LEONG L MORGAN R RASCHKO J SHIBATA S SOMLO G TETEF M
Citation: K. Margolin et al., TREATMENT OF GERM-CELL CANCER WITH 2 CYCLES OF HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE WITH AUTOLOGOUS STEM-CELL SUPPORT, Journal of clinical oncology, 14(10), 1996, pp. 2631-2637
SPLIT SCHEDULE REINFUSION OF G-CSF PRIMED PERIPHERAL STEM-CELLS (PSC), BUT NOT CD34-DOSE CHEMOTHERAPY (HDCT)( SELECTED PSC ENHANCES HEMATOPOIETIC RECOVERY IN PATIENTS (PTS) FOLLOWING HIGH)
Authors: SOMLO G SNIECINKEI I AHN C CHOW W HAMASAKI V LEONG L MARGOLI K MORGAN R RASCHKO J SHIBATA S TETEF M YON Y MOLINA A FORMAN S DOROSHOW J
Citation: G. Somlo et al., SPLIT SCHEDULE REINFUSION OF G-CSF PRIMED PERIPHERAL STEM-CELLS (PSC), BUT NOT CD34-DOSE CHEMOTHERAPY (HDCT)( SELECTED PSC ENHANCES HEMATOPOIETIC RECOVERY IN PATIENTS (PTS) FOLLOWING HIGH), Blood, 86(10), 1995, pp. 1531-1531
PRIMING WITH G-CSF 10 MU-G KG IS MORE EFFECTIVE THAN 5 MU-G/KG IN PATIENTS (PTS) RECEIVING HIGH-DOSE CHEMOTHERAPY (HDCT) FOLLOWED BY PERIPHERAL STEM-CELL (PSC) RESCUE/
Authors: SOMLO G SNIECINSKI I AHN C DOROSHOW J FORMAN S MARGOLIN K LEONG L MORGAN R RASCHKO J HAMASAKI V AKMAN S MOLINA A BRENT J BAKER P
Citation: G. Somlo et al., PRIMING WITH G-CSF 10 MU-G KG IS MORE EFFECTIVE THAN 5 MU-G/KG IN PATIENTS (PTS) RECEIVING HIGH-DOSE CHEMOTHERAPY (HDCT) FOLLOWED BY PERIPHERAL STEM-CELL (PSC) RESCUE/, Blood, 82(10), 1993, pp. 10000642-10000642
Risultati: 1-9 |